The Effects of Testosterone Supplementation in Aging Men with Heart Failure
Not Applicable
- Conditions
- Health Condition 1: I00-I99- Diseases of the circulatory system
- Registration Number
- CTRI/2021/01/030307
- Lead Sponsor
- All India Institute of Medical Sciences Rishilesh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Chronic Stable Heart Failure whose treatment has not been modified for the last 4 weeks
2)NYHA II/III
3)Testosterone Naive patients
4)Willing to give informed consent
Exclusion Criteria
1)Any Contraindication to transdermal Testosterone therapy
2)Deranged Prostate Specific Antigen
3)Deranged Renal Function
3)Any ongoing or past malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvements in Functional Capacity assessed by 6 Minutes Walk TestTimepoint: 12 weeks
- Secondary Outcome Measures
Name Time Method Improvements in Frailty assessed using Fried Frailty CriteriaTimepoint: 12 weeks;Improvements in Quality of Life assessed using Kansas City Cardiomyopathy QuestionnaireTimepoint: 12 weeks